RxDoctor Payments Data

Jonathan Epstein

Internal Medicine · Philadelphia, PANPI 1689601585

Payments from drug & device makers

What this record shows

This record is dominated by other: $13,127,854 of the $13,140,160 with a category attached, or 99.9%. AbbVie accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $13,127,854, more than ten times the $7,339 reported in 2022. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,140,160in general payments, 2019–2025

Across 5 payments — averaging $2,628,032 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13.1M
  • Astrazeneca UK Limited$5K
  • AstraZeneca$5K
  • Regeneron$3K

What the payments were for

  • Consulting fees$12,3060%
  • Other$13,127,854100%

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1$13,127,854
Astrazeneca UK Limited1$4,967
AstraZeneca2$4,833
Regeneron1$2,506

How this compares

$13,140,160 in reported general payments places this provider in the 95th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania →

Other internal medicine in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →